[96a5a0]: / output / allTrials / identified / NCT05867420_identified.json

Download this file

349 lines (349 with data), 14.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
{
"info": {
"nct_id": "NCT05867420",
"official_title": "A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASKG915 as a Single Agent in Patients With Selected Advanced Solid Tumors.",
"inclusion_criteria": "1. Histologically or cytologically confirmed advanced malignant tumor that is refractory to or intolerant of all standard therapy or for which no standard therapy is available.\n2. ECOG performance status of ≤ 2.\n3. Life expectancy of ≥ 3 months.\n4. The results of the laboratory tests must meet all criteria.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "1. Patients have received antitumor therapy during the first 4 weeks before study drug use.\n2. Received a live attenuated vaccine within 4 weeks prior to C1D1.\n3. Known cerebral parenchymal metastasis or meningeal metastasis.\n4. History of serious cardiovascular or cerebrovascular diseases.\n5. Active or recurrent autoimmune diseases.\n6. History of ascites or pleural effusion requiring drainage.\n7. Pregnant or lactating or planning to become pregnant at any time during the study, including the Follow-up Period.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. Histologically or cytologically confirmed advanced malignant tumor that is refractory to or intolerant of all standard therapy or for which no standard therapy is available.",
"criterions": [
{
"exact_snippets": "Histologically or cytologically confirmed advanced malignant tumor",
"criterion": "advanced malignant tumor",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": [
"histologically",
"cytologically"
]
}
]
},
{
"exact_snippets": "refractory to or intolerant of all standard therapy",
"criterion": "standard therapy",
"requirements": [
{
"requirement_type": "response",
"expected_value": [
"refractory",
"intolerant"
]
}
]
},
{
"exact_snippets": "for which no standard therapy is available",
"criterion": "standard therapy",
"requirements": [
{
"requirement_type": "availability",
"expected_value": false
}
]
}
]
},
{
"line": "2. ECOG performance status of ≤ 2.",
"criterions": [
{
"exact_snippets": "ECOG performance status of ≤ 2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "3. Life expectancy of ≥ 3 months.",
"criterions": [
{
"exact_snippets": "Life expectancy of ≥ 3 months.",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
]
}
]
},
{
"line": "4. The results of the laboratory tests must meet all criteria.",
"criterions": [
{
"exact_snippets": "results of the laboratory tests",
"criterion": "laboratory test results",
"requirements": [
{
"requirement_type": "criteria",
"expected_value": "must meet all criteria"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Patients have received antitumor therapy during the first 4 weeks before study drug use.",
"criterions": [
{
"exact_snippets": "Patients have received antitumor therapy",
"criterion": "antitumor therapy",
"requirements": [
{
"requirement_type": "receipt",
"expected_value": true
}
]
},
{
"exact_snippets": "during the first 4 weeks before study drug use",
"criterion": "time since last antitumor therapy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 4,
"unit": "weeks"
}
]
}
}
]
}
]
},
{
"line": "2. Received a live attenuated vaccine within 4 weeks prior to C1D1.",
"criterions": [
{
"exact_snippets": "Received a live attenuated vaccine within 4 weeks prior to C1D1.",
"criterion": "live attenuated vaccine",
"requirements": [
{
"requirement_type": "receipt",
"expected_value": false
},
{
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 4,
"unit": "weeks"
}
]
}
}
]
}
]
},
{
"line": "3. Known cerebral parenchymal metastasis or meningeal metastasis.",
"criterions": [
{
"exact_snippets": "Known cerebral parenchymal metastasis",
"criterion": "cerebral parenchymal metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "meningeal metastasis",
"criterion": "meningeal metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "4. History of serious cardiovascular or cerebrovascular diseases.",
"criterions": [
{
"exact_snippets": "History of serious cardiovascular ... diseases.",
"criterion": "cardiovascular diseases",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "serious"
},
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "History of serious ... cerebrovascular diseases.",
"criterion": "cerebrovascular diseases",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "serious"
},
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "5. Active or recurrent autoimmune diseases.",
"criterions": [
{
"exact_snippets": "Active or recurrent autoimmune diseases",
"criterion": "autoimmune diseases",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"active",
"recurrent"
]
}
]
}
]
},
{
"line": "6. History of ascites or pleural effusion requiring drainage.",
"criterions": [
{
"exact_snippets": "History of ascites",
"criterion": "ascites",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "severity",
"expected_value": "requiring drainage"
}
]
},
{
"exact_snippets": "History of ... pleural effusion requiring drainage",
"criterion": "pleural effusion",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "severity",
"expected_value": "requiring drainage"
}
]
}
]
},
{
"line": "7. Pregnant or lactating or planning to become pregnant at any time during the study, including the Follow-up Period.",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "lactating",
"criterion": "lactation status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "planning to become pregnant",
"criterion": "pregnancy planning",
"requirements": [
{
"requirement_type": "intention",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}